What is Potocki-Lupski syndrome

Potocki-Lupski syndrome (PTLS) is a rare genetic disorder caused by a duplication of a small piece of chromosome 17, which disrupts typical development and often results in intellectual disability, developmental delays, and cardiac or neurological differences. While symptoms vary significantly between individuals, early intervention and multidisciplinary support are essential for managing the long-term health and developmental needs of those diagnosed with Potocki-Lupski syndrome.

What causes Potocki-Lupski syndrome?

Potocki-Lupski syndrome is caused by a microduplication of genetic material on the short arm of chromosome 17, specifically at the 17p11.2 region. This region contains several genes that are critical for normal development. When an individual has an extra copy of these genes, it alters the delicate balance of proteins required for brain development, heart function, and physical growth. In most cases, Potocki-Lupski syndrome is a de novo event, meaning it occurs spontaneously in the egg or sperm cell and is not inherited from either parent. However, in rare instances, a parent may carry a balanced rearrangement of the chromosome that leads to the duplication in their child.

What are the primary clinical features of Potocki-Lupski syndrome?

Because the genetic duplication affects multiple systems, the clinical presentation of Potocki-Lupski syndrome is highly variable. While no two individuals are exactly alike, several common health and developmental issues are frequently observed in the community of 14 people currently mapped on DiseaseMaps.org and in global clinical studies:

• Developmental and Cognitive Impact: Most children with Potocki-Lupski syndrome experience mild to moderate intellectual disability and delays in reaching speech and motor milestones.


• Cardiac Involvement: Approximately 75% of individuals with the syndrome have congenital heart defects, such as atrial or ventricular septal defects.


• Neurological and Behavioral Traits: Many individuals exhibit features on the autism spectrum, sleep apnea, and hypotonia (low muscle tone) during infancy.


• Physical Growth: Feeding difficulties are common in early childhood, often followed by a tendency toward obesity or rapid weight gain in later childhood.

How common is Potocki-Lupski syndrome?

Potocki-Lupski syndrome is categorized as a rare disease, with an estimated prevalence of approximately 1 in 25,000 individuals. Because the condition can present with mild or non-specific symptoms, it is highly likely that many cases remain undiagnosed or misdiagnosed, suggesting the true prevalence may be higher. There is no known predilection for any specific gender, ethnicity, or geographic region; it appears to occur with equal frequency across all populations worldwide.

How is Potocki-Lupski syndrome diagnosed and distinguished?

Diagnosis is confirmed through chromosomal microarray (CMA) testing, a high-resolution genetic test that can identify the specific 17p11.2 duplication. It is important to distinguish Potocki-Lupski syndrome from Smith-Magenis syndrome. While both involve the same 17p11.2 region, Smith-Magenis syndrome is caused by a deletion of this genetic material rather than a duplication, resulting in a distinct, often opposite, set of physical and behavioral characteristics.

Next steps

• Consult with a clinical geneticist to review microarray results and discuss family screening.


• Schedule an evaluation with a pediatric cardiologist to screen for structural heart anomalies.


• Connect with the Potocki-Lupski syndrome community on DiseaseMaps.org to share experiences and find peer support.


• Coordinate with early intervention services, including speech, occupational, and physical therapy, to support developmental progress.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Potocki-Lupski syndrome overview.


• Orphanet: Rare disease database entry for 17p11.2 duplication syndrome.


• OMIM (Online Mendelian Inheritance in Man): Entry #610883 regarding the 17p11.2 duplication.


• Potocki-Lupski Syndrome Foundation: Educational resources and patient support initiatives.